MapLight Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MPLT Nasdaq 2830 www.maplightrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for MapLight Therapeutics, Inc.

MapLight CEO on what investors missed in the biotech’s schizophrenia data - Jul 29th, 2026 11:22 am
MapLight Therapeutics stock crashes on Phase II schizophrenia data - Jul 28th, 2026 9:06 am
MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose - Jul 27th, 2026 5:08 pm
Top Midday Decliners - Jul 27th, 2026 12:17 pm
Maplight Therapeutics’ Schizophrenia Drug Hits Phase II Primary Endpoint - Jul 27th, 2026 11:02 am
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia - Jul 27th, 2026 5:00 am
Is MapLight Therapeutics (MPLT) Fully Valued As Its Shares Hold Near $36.56? - Jul 26th, 2026 8:07 am
Sector Update: Healthcare Stocks Rise Late Afternoon - Jul 21st, 2026 1:40 pm
Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls - Jul 21st, 2026 7:40 am
Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout? - Jun 30th, 2026 7:22 am
MapLight Therapeutics Announces Changes to Board of Directors - Jun 24th, 2026 5:00 am
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder - Jun 22nd, 2026 5:00 am
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles - Jun 8th, 2026 5:16 am
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million - May 31st, 2026 8:39 am
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean - May 30th, 2026 10:48 am
MapLight's CFO Just Sold 36,000 Shares for $1 Million. Is It a Buy, Sell, or Hold? - May 15th, 2026 12:43 pm
MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - May 14th, 2026 2:05 pm
MapLight Therapeutics to Participate in Upcoming Investor Conferences - May 8th, 2026 5:00 am
This MapLight Insider Sold 69,000 Shares for $2.1 Million at the End of April - May 4th, 2026 9:29 am
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results - May 1st, 2026 5:00 am